Purchase Order 75N92B18P00024

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,887.00 on July 5, 2018. Place of performance is Pleasanton, California. The order covers genomic analysis instruments, consumables, or bioinformatics software supplied by the vendor. No set-aside applied. Ultimate completion date is July 5, 2018.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $20,509.00 on July 9, 2018, with completion on July 8, 2019. Performance took place in Pleasanton, California. The order was issued on a firm fixed price basis with no small business set-aside. The source does not specify the items or services procured.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $23,534.00 on August 7, 2018. Performance is located in Pleasanton, California. The order period runs from August 7, 2018 through August 6, 2019. 10X Genomics supplies single-cell and spatial transcriptomics platforms, reagents, and consumables to federal research agencies.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $22,310.60 on February 19, 2019, with completion on February 18, 2020. No set-aside was used. Performance occurs in Pleasanton, California. The order is priced on a firm fixed price basis for commercial genomic analysis instruments, consumables, or bioinformatics software supporting the institute's research operations.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $21,581.00 on June 19, 2018, with ultimate completion on July 19, 2018. No set-aside was used. Work is performed in Pleasanton, California. The order procures genomic analysis instruments, consumables, or reagents consistent with the vendor's core capability in single-cell and spatial transcriptomics platforms and associated products supplied to federal research...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,124.00 on September 20, 2019, with completion on September 27, 2019. The order is a firm fixed price, commercial item acquisition with no set-aside. Place of performance is Bethesda, Maryland. The purchase order procures genomic analysis instruments, consumables, or related bioinformatics products from 10X Genomics' single-cell and spatial transcriptomics...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $24,119.00 on March 5, 2020, with completion by March 12, 2020. No set-aside was used. Performance occurred in Pleasanton, California. The order was issued on a firm fixed price basis for genomic analysis products and related supplies.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a purchase order to 10X Genomics, Inc. valued at $21,581 with an award date of December 12, 2017. Work is performed in Bethesda, Maryland. The order covers genomic analysis instruments and consumables under a firm fixed price arrangement with a period of performance from December 12, 2017 through December 11, 2018.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. on August 20, 2018, with a ceiling value of $23,245.00 and a firm fixed price. No set-aside was used. Performance is located in Pleasanton, California. The order was ultimately completed on August 19, 2019.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $21,136.00 on April 3, 2019, with final completion on April 26, 2019. No set-aside was used. Place of performance is Yountville, California. The order covers genomic analysis instrumentation, consumables, or reagent kits supplied under firm fixed price terms.</p>